期刊文献+

2012年浙江省疑似药品不良反应死亡病例报告分析 被引量:4

Analysis of suspected deaths from adverse drug reactions in Zhejiang province in 2012
原文传递
导出
摘要 目的:分析药品在使用过程中可能导致患者死亡的主要特点和一般规律,为临床安全、合理用药提供参考。方法:对2012年浙江省药品不良反应监测中心收到的23例疑似药品不良反应死亡病例报告进行统计与分析。结果:抗感染药物引起的疑似死亡病例最为多见(25.35%);给药途径以静脉滴注所占比例最大(71.83%);超过半数病例在用药后2 h内出现不良反应症状(78.30%);患者死因中,因过敏样反应和过敏性休克导致死亡最为多见(47.80%),其次为循环系统损伤、呼吸系统损伤致死等。结论:导致药品严重不良反应甚至死亡的主要因素可能为抗感染药物或静脉滴注给药方式的广泛应用,临床不合理用药和药品质量的良莠不齐等。应加强临床合理用药,提高药品质量控制水平。 Objective: To investigate the features and general pattern of suspected deaths caused by drug uses for providing references of clinically rational and safe use of drugs. Methods : A total of 23 deaths collected in Zhejiang center for ADR monitoring in 2012 were analyzed retrospectively. Results: A total of 71 drugs were in- volved in the 23 deaths, among which the main type was anti-infective drugs (25.35%). The main route of admin- istration was by intravenous drip (71.83%). More than half of the deaths appeared symptoms of adverse reactions within 2 hours after using the drugs. Death resulted from allergic-like reactions and anaphylactic shock was the most common (47.80%) , followed by circulatory system damage and respiratory injury. Conclusion: ADR monitoring and reporting should be strengthened to ensure clinically safe, effective and rational drug use. The drug-related sus- pected deaths are mainly induced by the popular use of anti-infective drugs, and intravenous use of the drugs. Be- cause of existing unreasonable drug use and uneven qualities of drugs, control measures of rational drug use should be tightened.
出处 《中国新药杂志》 CAS CSCD 北大核心 2013年第19期2336-2340,共5页 Chinese Journal of New Drugs
关键词 药品不良反应 死亡 报告分析 合理用药 adverse drug reaction death analysis of reports rational use of drug
  • 相关文献

参考文献5

二级参考文献34

  • 1郭海平,刘军艳,杨本明,张新萍.10种中药注射剂不良反应文献分析[J].中国药物应用与监测,2007,4(2):57-59. 被引量:27
  • 2龙惠,于海江.中药注射剂不良反应的特点及其相关因素分析[J].中国药房,2007,18(21):1660-1662. 被引量:34
  • 3吴松寒.木通所致急性肾功能衰竭2例报告[J].江苏中医,1964,10:12-12.
  • 4闫素英,褚燕琦,张维,王育琴.281例中药注射剂不良反应报告分析[J].临床药物治疗杂志,2007,5(4):58-61. 被引量:19
  • 5国家药品不良反应监测中心.药品不良反应报告和监测工作手册[M].北京,2005,9:63.
  • 6国家药品不良反应中心编译.WHO药品不良反应术语集[M].北京:中国医药科技出版社,2003:157-169.
  • 7杨华,赵艳娇,耿凤英,金丹.838例中药注射剂不良反应分析[J].实用药物与临床,2007,10(4):228-229. 被引量:40
  • 8LEBEAU C, DEBELLE FD, ARLT VM,et al. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies [ J ]. Nephrol Dial Transplant, 2005,20(11 ) :2321 -2332.
  • 9MEINL W, PABEL U, OSTERLOH-QUIROZ M,et al. Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue [ J ]. Int J Cancer, 2006,118(5) :1090 - 1097.
  • 10ZHANG CY, WANG X, SU T,et al. New aristolochic acid, aristololactam and renal eytotoxic constituents from the stem and leaves of Aristolochia contorta [ J ]. Pharmazie , 2005,60 (10) :785 - 788.

共引文献62

同被引文献24

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部